help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huhtaniemi, I. T.
Right arrow Articles by Catt, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huhtaniemi, I. T.
Right arrow Articles by Catt, K. J.

Endocrinology, Vol 109, 483-490, Copyright © 1981 by Endocrine Society


ARTICLES

Induction and maintenance of gonadotropin and lactogen receptors in hypoprolactinemic rats

IT Huhtaniemi and KJ Catt

The effect of 2-bromo-alpha-ergocriptine (BR)-induced hypoprolactinemia on the induction and maintenance of testicular gonadotropin and lactogen receptors was studied in 60-day-old rats after receptor regulation by a gonadotropin-releasing hormone agonist analog [[D-Ser- (tBu)6]des-Gly10-GnRH N-ethylamide (GnRH-A)] and in young animals during sexual maturation. In adult animals, BR treatment delayed the reappearance of LH binding in the testis after GnRH-A injection, but had no effect on the recovery of lactogen binding. BR treatment also inhibited the increase of LH binding that occurred in control animals during the experimental period, but did not affect lactogen binding. Furthermore, BR potentiated the effect of GnRH-A on the decrease of Leydig cell testosterone synthesis observed 2 days later in vitro. Eight days after GnRH-A injection, concomitant BR treatment significantly inhibited the recovery of Leydig cell cAMP production. In peripubertal (25- to 46-day-old) animals, BR diminished the normal rise in testicular LH receptors, but did not affect the increase in lactogen receptors. Serum testosterone levels and other features of pubertal development, such as balano-preputial separation and spermatogenesis, were unaffected by hypoprolactinemia. In neonatal female animals, significant lactogen binding was detected at 3 days of age, whereas hCG binding was not demonstrable until 9 days after birth. These findings indicate that the expression of lactogen receptors precedes that of LH receptors in the developing gonad, and that the increase of LH binding in the testis during pubertal development requires normal circulating PRL levels. In adult animals, hypoprolactinemia potentiates GnRH-A- induced desensitization of steroidogenesis and cAMP formation, as well as LH receptor down-regulation, delaying the recovery of these phenomena. Although decreased serum PRL levels were associated with a marked reduction in testicular LH receptors both during development and in adult life, the absence of changes in lactogen receptors indicates that the latter sites are largely independent of the circulating PRL concentration.


This article has been cited by other articles:


Home page
EndocrinologyHome page
H. P. Mohammad, R. A. Abbud, A. F. Parlow, J. S. Lewin, and J. H. Nilson
Targeted Overexpression of Luteinizing Hormone Causes Ovary-Dependent Functional Adenomas Restricted to Cells of the Pit-1 Lineage
Endocrinology, October 1, 2003; 144(10): 4626 - 4636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. T. Kero, E. Savontaus, M. Mikola, U. Pesonen, M. Koulu, R. A. Keri, J. H. Nilson, M. Poutanen, and I. T. Huhtaniemi
Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E812 - E818.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
R. J. Mann, R. A. Keri, and J. H. Nilson
Consequences of Elevated Luteinizing Hormone on Diverse Physiological Systems: Use of the LH{beta}CTP Transgenic Mouse as a Model of Ovarian Hyperstimulation-induced Pathophysiology
Recent Prog. Horm. Res., January 1, 2003; 58(1): 343 - 375.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Piltonen, R. Koivunen, L. Morin-Papunen, A. Ruokonen, I.T. Huhtaniemi, and J.S. Tapanainen
Ovarian and adrenal steroid production: regulatory role of LH/HCG
Hum. Reprod., March 1, 2002; 17(3): 620 - 624.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. S. Marty, J. W. Crissman, and E. W. Carney
Evaluation of the Male Pubertal Assay's Ability to Detect Thyroid Inhibitors and Dopaminergic Agents
Toxicol. Sci., March 1, 2001; 60(1): 63 - 76.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. R. Manna, T. El-Hefnawy, J. Kero, and I. T. Huhtaniemi
Biphasic Action of Prolactin in the Regulation of Murine Leydig Tumor Cell Functions
Endocrinology, January 1, 2001; 142(1): 308 - 318.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Tena-Sempere, A. Rannikko, J. Kero, F.-P. Zhang, and I. T. Huhtaniemi
Molecular Mechanisms of Reappearance of Luteinizing Hormone Receptor Expression and Function in Rat Testis after Selective Leydig Cell Destruction by Ethylene Dimethane Sulfonate
Endocrinology, August 1, 1997; 138(8): 3340 - 3348.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society